Market Overview:
The global devices for inhaled medications market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of respiratory diseases, growing geriatric population, and technological advancements in inhalers. The global devices for inhaled medications market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into dry powder inhalers (DPIs), metered-dose inhalers (MDIs), nebulizers, and soft mist inhalers (SMIs). DPIs are further sub-segmented into pressurized DPI systems and breath-activated DPI systems. MDIs are further sub-segmented into single dose MDI systems and multiple dose MDI systems. Nebulizers are further sub-segmented into compressor nebulizers and ultrasonic nebulizers. SMIs are further sub-segmented into battery powered SMIs and manual SMIs. On the basis of application, the market is segmented into clinic settings, hospital settings, home settings.,and others which include long term care facilities & military hospitals etc.). Clinic settings account for majority share in terms of revenue generated by this market due to high adoption rates across developed countries such as U S A , Canada , Germany , France etc .
Product Definition:
Device for Inhaled Medications is a machine that helps people to take their medicine in the form of a mist or vapor. Devices for Inhaled Medication can help to ensure that the medication gets deep into the lungs, where it is needed most. This can be important for people with asthma or other respiratory problems, who need to get the most out of their medications.
Dry Powder Inhalers:
Dry powder inhalers (DPIs) are a category of respiratory devices that deliver medication through the mouth using compressed air. They were approved by the U.S. FDA in 1996 and have been used extensively ever since, with over 17 million users currently in America alone as of 2015.
Metered-Dose Inhalers:
Metered-dose inhalers (MDI) are devices used to deliver a metered amount of drug by using compressed air or liquid propellant. MDI’s work in the same way as an asthma inhaler but with more precision and care. The medicine is dispensed either by gravity or from a spacer at the push of a button. They are easy to use, portable, and safe for people of all ages and physical abilities.
Application Insights:
The clinic application segment dominated the global devices for inhalation medications market in 2017. This is attributed to growing awareness about asthma and other lung diseases, increasing number of clinics, and availability of advanced healthcare facilities. For instance, according to a study published by the CDC in September 2016, around 30 million adults aged more than 18 years have asthma. The disease burden owing to asthma is huge as it resulted in over 3,000 deaths in 2014. With such statistics showing that around 1 out of every 2 adults has some form of this chronic respiratory disease worldwide; there is a high demand for inhalation medication across clinics worldwide which will drive growth during the forecast period.
Hospital application segment will expand at a CAGR close to 7% from 2018 to 2030 due largely on an increase in hospital admissions due largely on an increase hospital construction activities globally coupled with technological advancements such as introduction of new drugs.
Regional Analysis:
North America dominated the global devices for inhaled medications market in 2016. This can be attributed to factors such as technological advancements, high disposable income of patients, and presence of well-established healthcare facilities. Moreover, increasing prevalence of chronic respiratory diseases is expected to drive growth over the forecast period. According to a study published by CDC in 2014’s Morbidity & Mortality Weekly Report (MMWR), around 15 million people were diagnosed with COPD and around 6 million died due to this condition in U.S.
Asia Pacific region is expected witness lucrative growth over the next eight years owing to rising awareness about available treatment options among patients coupled with growing target population base especially in India and China.
Growth Factors:
- Increasing prevalence of respiratory diseases: The Devices for Inhaled Medications market is driven by the increasing prevalence of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. According to the World Health Organization (WHO), over 300 million people suffer from asthma, and COPD is the third leading cause of death worldwide.
- Growing demand for novel therapies: The Devices for Inhaled Medications market is also driven by the growing demand for novel therapies that can improve patient outcomes and reduce healthcare costs. For instance, dry powder inhalers are becoming increasingly popular due to their ease of use and superior performance compared to other devices such as metered dose inhalers (MDIs).
- Technological advancements: The Devices for Inhaled Medications market is also propelled by technological advancements in device design and formulation that have made these products more user-friendly and effective than ever before. For example, recent advances in drug delivery technologies have led to the development of next-generation dry powder inhalers that are easier to use than traditional devices and deliver drugs directly to the lungs with greater precision.
- Rising awareness about respiratory health: There has been a growing awareness among patients about the importance of respiratory health in recent years, which has helped fuel demand for Devices for Inhaled Medications products globally. This trend is likely to continue in coming years as more people become aware of how these devices can help manage
Scope Of The Report
Report Attributes
Report Details
Report Title
Devices for Inhaled Medications Market Research Report
By Type
Dry Powder Inhalers, Metered-Dose Inhalers, Nebulizers, Soft Mist Inhaler
By Application
Clinic, Hospital, Home
By Companies
Consort Medical, Inhalexper, Cambridge Consultants, Hovione, Catalent, Inc, VertMarkets, Inc, Qualicaps, 3M, Aerovance, AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, Civitas/Alkermes, GlaxoSmithKline, Hovione, Mannkind, Mantecorp, Meda, MicroDose Therapeutx, Novartis
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
246
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Devices for Inhaled Medications Market Report Segments:
The global Devices for Inhaled Medications market is segmented on the basis of:
Types
Dry Powder Inhalers, Metered-Dose Inhalers, Nebulizers, Soft Mist Inhaler
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Clinic, Hospital, Home
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Consort Medical
- Inhalexper
- Cambridge Consultants
- Hovione
- Catalent, Inc
- VertMarkets, Inc
- Qualicaps
- 3M
- Aerovance
- AstraZeneca
- Boehringer Ingelheim
- Chiesi
- Cipla
- Civitas/Alkermes
- GlaxoSmithKline
- Hovione
- Mannkind
- Mantecorp
- Meda
- MicroDose Therapeutx
- Novartis
Highlights of The Devices for Inhaled Medications Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Dry Powder Inhalers
- Metered-Dose Inhalers
- Nebulizers
- Soft Mist Inhaler
- By Application:
- Clinic
- Hospital
- Home
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Devices for Inhaled Medications Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Devices for inhaled medications are devices that help people breathe in medications. They come in different shapes and sizes, and can be worn on the face or around the neck.
Some of the key players operating in the devices for inhaled medications market are Consort Medical, Inhalexper, Cambridge Consultants, Hovione, Catalent, Inc, VertMarkets, Inc, Qualicaps, 3M, Aerovance, AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, Civitas/Alkermes, GlaxoSmithKline, Hovione, Mannkind, Mantecorp, Meda, MicroDose Therapeutx, Novartis.
The devices for inhaled medications market is expected to register a CAGR of 5.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Devices for Inhaled Medications Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Devices for Inhaled Medications Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Devices for Inhaled Medications Market - Supply Chain
4.5. Global Devices for Inhaled Medications Market Forecast
4.5.1. Devices for Inhaled Medications Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Devices for Inhaled Medications Market Size (000 Units) and Y-o-Y Growth
4.5.3. Devices for Inhaled Medications Market Absolute $ Opportunity
5. Global Devices for Inhaled Medications Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Devices for Inhaled Medications Market Size and Volume Forecast by Type
5.3.1. Dry Powder Inhalers
5.3.2. Metered-Dose Inhalers
5.3.3. Nebulizers
5.3.4. Soft Mist Inhaler
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Devices for Inhaled Medications Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Devices for Inhaled Medications Market Size and Volume Forecast by Application
6.3.1. Clinic
6.3.2. Hospital
6.3.3. Home
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Devices for Inhaled Medications Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Devices for Inhaled Medications Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Devices for Inhaled Medications Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Devices for Inhaled Medications Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Devices for Inhaled Medications Demand Share Forecast, 2019-2026
9. North America Devices for Inhaled Medications Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Devices for Inhaled Medications Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Devices for Inhaled Medications Market Size and Volume Forecast by Application
9.4.1. Clinic
9.4.2. Hospital
9.4.3. Home
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Devices for Inhaled Medications Market Size and Volume Forecast by Type
9.7.1. Dry Powder Inhalers
9.7.2. Metered-Dose Inhalers
9.7.3. Nebulizers
9.7.4. Soft Mist Inhaler
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Devices for Inhaled Medications Demand Share Forecast, 2019-2026
10. Latin America Devices for Inhaled Medications Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Devices for Inhaled Medications Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Devices for Inhaled Medications Market Size and Volume Forecast by Application
10.4.1. Clinic
10.4.2. Hospital
10.4.3. Home
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Devices for Inhaled Medications Market Size and Volume Forecast by Type
10.7.1. Dry Powder Inhalers
10.7.2. Metered-Dose Inhalers
10.7.3. Nebulizers
10.7.4. Soft Mist Inhaler
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Devices for Inhaled Medications Demand Share Forecast, 2019-2026
11. Europe Devices for Inhaled Medications Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Devices for Inhaled Medications Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Devices for Inhaled Medications Market Size and Volume Forecast by Application
11.4.1. Clinic
11.4.2. Hospital
11.4.3. Home
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Devices for Inhaled Medications Market Size and Volume Forecast by Type
11.7.1. Dry Powder Inhalers
11.7.2. Metered-Dose Inhalers
11.7.3. Nebulizer
11.7.4. Soft Mist Inhaler
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Devices for Inhaled Medications Demand Share, 2019-2026
12. Asia Pacific Devices for Inhaled Medications Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Devices for Inhaled Medications Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Devices for Inhaled Medications Market Size and Volume Forecast by Application
12.4.1. Clinic
12.4.2. Hospital
12.4.3. Home
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Devices for Inhaled Medications Market Size and Volume Forecast by Type
12.7.1. Dry Powder Inhalers
12.7.2. Metered-Dose Inhalers
12.7.3. Nebulizers
12.7.4. Soft Mist Inhaler
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Devices for Inhaled Medications Demand Share, 2019-2026
13. Middle East & Africa Devices for Inhaled Medications Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Devices for Inhaled Medications Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Devices for Inhaled Medications Market Size and Volume Forecast by Application
13.4.1. Clinic
13.4.2. Hospital
13.4.3. Home
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Devices for Inhaled Medications Market Size and Volume Forecast by Type
13.7.1. Dry Powder Inhalers
13.7.2. Metered-Dose Inhalers
13.7.3. Nebulizers
13.7.4. Soft Mist Inhaler
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Devices for Inhaled Medications Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Devices for Inhaled Medications Market: Market Share Analysis
14.2. Devices for Inhaled Medications Distributors and Customers
14.3. Devices for Inhaled Medications Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Consort Medical
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Inhalexper
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Cambridge Consultants
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Hovione
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Catalent, Inc
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. VertMarkets, Inc
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Qualicaps
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. 3M
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Aerovance
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. AstraZeneca
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Boehringer Ingelheim
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Chiesi
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Cipla
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Civitas/Alkermes
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. GlaxoSmithKline
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Hovione
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Mannkind
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. Mantecorp
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. Meda
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. MicroDose Therapeutx
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
